Literature DB >> 34694903

Structure of the Streptococcus pyogenes NAD+ Glycohydrolase Translocation Domain and Its Essential Role in Toxin Binding to Oropharyngeal Keratinocytes.

Jorge J Velarde1, Alessandro Piai2, Ian J Lichtenstein1, Nicola N Lynskey1, James J Chou2, Michael R Wessels1.   

Abstract

The emergence and continued dominance of a Streptococcus pyogenes (group A Streptococcus, GAS) M1T1 clonal group is temporally correlated with acquisition of genomic sequences that confer high level expression of cotoxins streptolysin O (SLO) and NAD+-glycohydrolase (NADase). Experimental infection models have provided evidence that both toxins are important contributors to GAS virulence. SLO is a cholesterol-dependent pore-forming toxin capable of lysing virtually all types of mammalian cells. NADase, which is composed of an N-terminal translocation domain and C-terminal glycohydrolase domain, acts as an intracellular toxin that depletes host cell energy stores. NADase is dependent on SLO for internalization into epithelial cells, but its mechanism of interaction with the cell surface and details of its translocation mechanism remain unclear. In this study we found that NADase can bind oropharyngeal epithelial cells independently of SLO. This interaction is mediated by both domains of the toxin. We determined by NMR the structure of the translocation domain to be a β-sandwich with a disordered N-terminal region. The folded region of the domain has structural homology to carbohydrate binding modules. We show that excess NADase inhibits SLO-mediated hemolysis and binding to epithelial cells in vitro, suggesting NADase and SLO have shared surface receptors. This effect is abrogated by disruption of a putative carbohydrate binding site on the NADase translocation domain. Our data are consistent with a model whereby interactions of the NADase glycohydrolase domain and translocation domain with SLO and the cell surface increase avidity of NADase binding and facilitate toxin-toxin and toxin-cell surface interactions. IMPORTANCE NADase and streptolysin O (SLO) are secreted toxins important for pathogenesis of group A Streptococcus, the agent of strep throat and severe invasive infections. The two toxins interact in solution and mutually enhance cytotoxic activity. We now find that NADase is capable of binding to the surface of human cells independently of SLO. Structural analysis of the previously uncharacterized translocation domain of NADase suggests that it contains a carbohydrate binding module. The NADase translocation domain and SLO appear to recognize similar glycan structures on the cell surface, which may be one mechanism through which NADase enhances SLO pore-forming activity during infection. Our findings provide new insight into the NADase toxin and its functional interactions with SLO during streptococcal infection.

Entities:  

Keywords:  NADase; NMR spectroscopy; Streptococcus pyogenes; cell binding; nuclear magnetic resonance; toxin; toxins

Mesh:

Substances:

Year:  2021        PMID: 34694903      PMCID: PMC8765395          DOI: 10.1128/JB.00366-21

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.476


  54 in total

1.  Characterization of Streptococcus pyogenes beta-NAD+ glycohydrolase: re-evaluation of enzymatic properties associated with pathogenesis.

Authors:  Joydeep Ghosh; Patricia J Anderson; Sukantha Chandrasekaran; Michael G Caparon
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

2.  The program XEASY for computer-supported NMR spectral analysis of biological macromolecules.

Authors:  C Bartels; T H Xia; M Billeter; P Güntert; K Wüthrich
Journal:  J Biomol NMR       Date:  1995-07       Impact factor: 2.835

3.  Evolutionary origin and emergence of a highly successful clone of serotype M1 group a Streptococcus involved multiple horizontal gene transfer events.

Authors:  Paul Sumby; Steve F Porcella; Andres G Madrigal; Kent D Barbian; Kimmo Virtaneva; Stacy M Ricklefs; Daniel E Sturdevant; Morag R Graham; Jaana Vuopio-Varkila; Nancy P Hoe; James M Musser
Journal:  J Infect Dis       Date:  2005-07-29       Impact factor: 5.226

4.  Specificity of Streptococcus pyogenes NAD(+) glycohydrolase in cytolysin-mediated translocation.

Authors:  Joydeep Ghosh; Michael G Caparon
Journal:  Mol Microbiol       Date:  2006-10-17       Impact factor: 3.501

5.  Structural basis of Streptococcus pyogenes immunity to its NAD+ glycohydrolase toxin.

Authors:  Craig L Smith; Joydeep Ghosh; Jennifer Stine Elam; Jerome S Pinkner; Scott J Hultgren; Michael G Caparon; Tom Ellenberger
Journal:  Structure       Date:  2011-02-09       Impact factor: 5.006

6.  NAD+-glycohydrolase acts as an intracellular toxin to enhance the extracellular survival of group A streptococci.

Authors:  Angela L Bricker; Colette Cywes; Cameron D Ashbaugh; Michael R Wessels
Journal:  Mol Microbiol       Date:  2002-04       Impact factor: 3.501

7.  A molecular trigger for intercontinental epidemics of group A Streptococcus.

Authors:  Luchang Zhu; Randall J Olsen; Waleed Nasser; Stephen B Beres; Jaana Vuopio; Karl G Kristinsson; Magnus Gottfredsson; Adeline R Porter; Frank R DeLeo; James M Musser
Journal:  J Clin Invest       Date:  2015-08-10       Impact factor: 14.808

8.  Regulation of T cell receptor activation by dynamic membrane binding of the CD3epsilon cytoplasmic tyrosine-based motif.

Authors:  Chenqi Xu; Etienne Gagnon; Matthew E Call; Jason R Schnell; Charles D Schwieters; Christopher V Carman; James J Chou; Kai W Wucherpfennig
Journal:  Cell       Date:  2008-11-14       Impact factor: 41.582

9.  TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts.

Authors:  Yang Shen; Frank Delaglio; Gabriel Cornilescu; Ad Bax
Journal:  J Biomol NMR       Date:  2009-06-23       Impact factor: 2.835

10.  Diverse modes of galacto-specific carbohydrate recognition by a family 31 glycoside hydrolase from Clostridium perfringens.

Authors:  Julie M Grondin; Da Duan; Alyssa C Kirlin; Kento T Abe; Seth Chitayat; Holly L Spencer; Craig Spencer; Alisha Campigotto; Scott Houliston; Cheryl H Arrowsmith; John S Allingham; Alisdair B Boraston; Steven P Smith
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.